SearcharxivSearch

arXiv subjects

David B. Ascher

Publications and source records attributed to David B. Ascher.

18 recordsLinked to original sources

ToxLens: A Reproducible Graph-Learning Framework for Leakage-Aware, Uncertainty-Calibrated Molecular Toxicity Prediction

Molecular toxicity prediction is increasingly used to prioritise compounds before experimental testing, but conventional benchmark performance can overstate practical utility when structurally related molecules occur across training and test folds. We introduce ToxLens, a reproducible multi-task graph-learning framework for 11 toxicity endpoints spanning Ames mutagenicity, acute oral toxicity, hERG inhibition, and Tox21 nuclear-receptor and stress-response assays. The workflow combines conservative chemical curation, sphere-exclusion filtering, a leakage-aware UMAP-HDBSCAN split, parallel graph and global-feature encoders joined by late concatenation, temperature-scaled Monte Carlo dropout with conformal-style prediction sets, applicability-domain analysis, and SHAP-guided toxicophore discovery with occlusion controls. On the leakage-controlled test fold, a five-seed soft-voting ensemble achieved a Matthews correlation coefficient score of 0.44, an area under the receiver operating characteristic curve score of 0.83, and an area under the precision-recall curve score of 0.58. It exceeded four ECFP4-based shallow baselines on all 11 endpoints under the same split and validation-based threshold-selection protocol. Controlled ablations showed that the global pathway was important, whereas late concatenation outperformed the tested gated and feature-wise linear modulation fusion variants. Conformal-style prediction sets revealed substantial endpoint-specific variation in set efficiency, and discrimination and calibration improved with similarity to the training domain. Retraining on fixed published Tox21 Challenge and TDA folds produced competitive, but not uniformly state-of-the-art, performance. SHAP-guided occlusion and consensus subgraph mining yielded model-derived structural hypotheses, 44 of which contained at least one occurrence that passed the predefined counterfactual criteria.

cs.LG

AnnotateMissense: a genome-wide annotation and benchmarking framework for missense pathogenicity prediction

Missense variant interpretation remains challenging because pathogenicity depends on heterogeneous evidence from population frequency, evolutionary conservation, transcript context, amino acid substitution severity, prior pathogenicity predictors and protein-language-model-derived features. We present AnnotateMissense, a scalable annotation, benchmarking and genome-wide prediction framework for missense variant interpretation. AnnotateMissense integrates hg38 missense variants derived from dbNSFP v5.1 with ANNOVAR annotations, dbNSFP transcript/protein descriptors, AlphaMissense scores, ESM-derived features, conservation metrics, population-frequency variables, established pathogenicity predictors and engineered amino acid/codon-context features. Using 132,714 ClinVar-labelled missense variants, we benchmarked machine-learning and deep-learning models under controlled feature configurations. The full 303-feature benchmark set achieved the strongest performance with XGBoost, reaching mean MCC = 0.9411 and ROC-AUC = 0.9950 across stratified five-fold cross-validation. Restricted naive and location-oriented feature sets achieved lower best MCC values of 0.4989 and 0.5113, respectively. Circularity-controlled ablations showed that removing prior-predictor, population-frequency and clinically overlapping evidence reduced performance, whereas excluding AlphaMissense and ESM-derived features alone had minimal effect. Temporal ClinVar validation on newly observed pathogenic/benign variants achieved MCC = 0.7613, accuracy = 0.8798 and F1-score = 0.8750. The final model was applied to 90,643,830 hg38 missense variants to generate AnnotateMissense pathogenicity scores and binary prediction labels. Code and outputs are available at https://github.com/MuhammadMuneeb007/CAGI7_Annotate_All_Missense and https://doi.org/10.5281/zenodo.19981867.

q-bio.GN

DPD-Cancer: Explainable Graph-Based Deep Learning for Small Molecule Anti-Cancer Activity Prediction

DPD-Cancer is a graph-attention deep learning framework for predicting small-molecule DPD-Cancer is a graph-attention deep learning framework for predicting small-molecule anti-cancer activity across the NCI-60 panel, trained and evaluated under a strict chemistry-aware data-partitioning scheme. On the hold-out test set, the classifier achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.87 (95% CI [0.86, 0.88]) and Area Under the Precision-Recall Curve (AUPRC) of 0.73 (95% CI [0.70, 0.76]); per-cell-line regression models for 73 cell lines produced a median Pearson's Correlation Coefficient (Pearson's R) of 0.64 and median Root Mean Squared Error (RMSE) of 0.67 for pGI50-value prediction. Benchmarks against pdCSM-Cancer, MLASM, and ACLPred under matched data conditions yielded consistently higher Matthew's Correlation Coefficient (MCC) scores, an occlusion-based attribution analysis confirmed that model explanations were quantitatively faithful to classifier decisions, and an applicability-domain analysis characterised reliability as a function of chemical distance. To facilitate widespread adoption, DPD-Cancer is available as a free, user-friendly web server for unrestricted use at https://biosig.lab.uq.edu.au/dpd_cancer/.

cs.LG

Benchmarking end-to-end genotype-to-phenotype prediction workflows across 80 openSNP phenotypes

Genotype-to-phenotype prediction is a central goal of statistical genetics, yet practical comparisons of prediction workflows remain limited in small, heterogeneous, participant-shared genomic datasets. Here, we benchmarked end-to-end case-control prediction across 80 curated binary phenotypes from openSNP using machine learning, deep learning, and polygenic score workflows. We evaluated 29 machine-learning algorithms, 80 deep-learning model variants, and 3 polygenic score tools across 675 clumping and pruning configurations. No workflow family dominated universally. Polygenic score workflows achieved the highest observed discrimination for 53 phenotypes, whereas machine-learning or deep-learning workflows achieved the highest for 27. However, many apparent phenotype-level wins were modest, with 41.2\% of comparisons representing practical ties within five discrimination points. Performance was strongly phenotype-dependent and sensitive to modeling and preprocessing choices. Distinct workflow-specific failure modes were also observed, including unstable behaviour in PRSice and non-informative collapse in lassosum for 13 phenotypes. Higher peak performance was concentrated in smaller phenotypes, reinforcing the need for cautious interpretation in limited-data settings. The cohort was predominantly of European ancestry, restricting generalisability. Together, these results position openSNP as a useful stress-test environment for genomic prediction and support benchmark-guided workflow selection under realistic conditions of data scarcity, phenotype heterogeneity, and ancestry imbalance.

q-bio.GN

PhenotypeToGeneDownloaderR: automated multi-source retrieval and validation of phenotype-associated genes

Identifying phenotype-associated genes is a common first step in polygenic risk score construction, enrichment testing, target prioritisation and variant interpretation, but relevant evidence is distributed across heterogeneous databases with different interfaces, formats and evidence models. Here, we present PhenotypeToGeneDownloaderR, a phenotype-guided R/Python pipeline for automated gene retrieval, harmonisation, symbol validation and cross-source summary analysis. Given a phenotype term, the pipeline queries integrated biological databases, standardises per-source outputs, combines gene lists, validates retrieved symbols against the NCBI human gene reference and generates summary tables and visualisations. Across 13 clinically relevant phenotypes and 13 databases, PhenotypeToGeneDownloaderR generated 136,487 raw gene retrievals, with at least one source returning genes for every phenotype. Across all 13 phenotypes, 100,175 of 114,345 combined input symbols were retained after direct or synonym-based validation, corresponding to an 87.6\% validation rate. Cross-source overlap was low, supporting the complementarity of integrated evidence sources. Against an HPO/ClinVar/OMIM-derived gold standard, the pipeline recovered 1,039 of 1,056 known phenotype-associated genes, corresponding to 98.4\% recall. PhenotypeToGeneDownloaderR provides a lightweight, reproducible upstream framework for generating candidate gene sets for downstream prioritisation and interpretation. The pipeline is implemented in R and Python, released under the MIT licence, and available at https://github.com/MuhammadMuneeb007/PhenotypeToGeneDownloaderR.

q-bio.GN

EFGPP: Exploratory framework for genotype-phenotype prediction

Predicting complex human traits from genetic data is challenging because different genetic, clinical, and molecular data sources often contain different parts of the signal. Here, we present EFGPP, a reproducible framework for generating, ranking, and combining multiple types of data for genotype-to-phenotype prediction. We applied EFGPP to migraine prediction using UK Biobank data from 733 individuals. The framework combined genotype-derived features, principal components, clinical and metabolomic covariates, and polygenic risk scores generated from migraine and depression GWAS using PLINK, PRSice-2, AnnoPred, and LDAK-GWAS. The best single data type achieved a test AUC of 0.644, while combining multiple data types improved performance to 0.688 using migraine-focused inputs and 0.663 using cross-trait depression-derived inputs. Genetic features alone did not outperform the covariates-only baseline, but genotype-derived features performed better than PRS alone, and depression-derived PRS showed useful predictive signal. Overall, EFGPP provides a practical proof-of-concept framework for prioritising and integrating heterogeneous genetic data sources for complex phenotype prediction.

q-bio.GN

Benchmarking Heritability Estimation Strategies Across 86 Configurations and Their Downstream Effect on Polygenic Risk Score Performance

Objective: SNP heritability estimates vary substantially across estimation strategies, yet the downstream consequences for polygenic risk score (PRS) construction remain poorly characterised. We systematically benchmarked heritability estimation configurations and assessed their propagation into downstream PRS performance. Methods: We benchmarked 86 heritability-estimation configurations spanning six tool families (GEMMA, GCTA, LDAK, DPR, LDSC, and SumHer) and ten method groups across 10 UK Biobank phenotypes, yielding 844 configuration-level estimates. Each estimate was propagated into GCTA-SBLUP and LDpred2-lassosum2 PRS frameworks and evaluated across five cross-validation folds using null, PRS-only, and full models. Eleven binary analytical contrasts were tested using Mann-Whitney U tests to identify drivers of heritability variability. Results: Heritability ranged from -0.862 to 2.735 (mean = 0.134, SD = 0.284), with 133 of 844 estimates (15.8%) being negative and concentrated in unconstrained estimation regimes. Ten of eleven analytical contrasts significantly affected heritability magnitude, with algorithm choice and GRM standardisation showing the largest effects. Despite this upstream variability, downstream PRS test performance was only weakly coupled to heritability magnitude: pooled Pearson correlations between h^2 and test AUC were r = -0.023 for GCTA-SBLUP and r = +0.014 for LDpred2-lassosum2, with both being non-significant. Conclusion: SNP heritability is best interpreted as a configuration-sensitive modelling parameter rather than a universally stable scalar input. Heritability estimates should always be reported alongside their full estimation specification, and downstream PRS performance is comparatively robust to moderate variation in the heritability input.

q-bio.GN

A harmonized benchmarking framework for implementation-aware evaluation of 46 polygenic risk score tools across binary and continuous phenotypes

Polygenic risk score (PRS) tools differ substantially in statistical assumptions, input requirements, and implementation complexity, making direct comparison difficult. We developed a harmonized, implementation-aware benchmarking framework to evaluate 46 PRS tools across seven binary UK Biobank phenotypes and one continuous trait under three model configurations: null, PRS-only, and PRS plus covariates. The framework integrates standardized preprocessing, tool-specific execution, hyperparameter exploration, and unified downstream evaluation using five-fold cross-validation on high-performance computing infrastructure. In addition to predictive performance, we assessed runtime, memory use, input dependencies, and failure modes. A Friedman test across 40 phenotype--fold combinations confirmed significant differences in tool rankings ($χ^2 = 102.29$, $p = 2.57 \times 10^{-11}$), with no single method universally optimal. These findings provide a reproducible framework for comparative PRS evaluation and demonstrate that tool performance is shaped not only by statistical methodology but also by phenotype architecture, preprocessing choices, covariate structure, computational demands, software robustness, and practical implementation constraints.

q-bio.GN

G2DR: A Genotype-First Framework for Genetics-Informed Target Prioritization and Drug Repurposing

Human genetics offers a promising route to therapeutic discovery, yet practical frameworks translating genotype-derived signal into ranked target and drug hypotheses remain limited, particularly when matched disease transcriptomics are unavailable. Here we present G2DR, a genotype-first prioritization framework propagating inherited variation through genetically predicted expression, multi-method gene-level testing, pathway enrichment, network context, druggability, and multi-source drug--target evidence integration. In a migraine case study with 733 UK Biobank participants under stratified five-fold cross-validation, we imputed expression across seven transcriptome-weight resources and ranked genes using a reproducibility-aware discovery score from training and validation data, followed by a balanced integrated score for target selection. Discovery-based prioritization generalized to held-out data, achieving gene-level ROC-AUC of 0.775 and PR-AUC of 0.475, while retaining enrichment for curated migraine biology. Mapping prioritized genes to compounds via Open Targets, DGIdb, and ChEMBL yielded drug sets enriched for migraine-linked compounds relative to a global background, though recovery favoured broader mechanism-linked and off-label space over migraine-specific approved therapies. Directionality filtering separated broadly recovered compounds from mechanistically compatible candidates. G2DR is a modular framework for genetics-informed hypothesis generation, not a clinically actionable recommendation system. All outputs require independent experimental, pharmacological, and clinical validation.

q-bio.GN

GWAS Summary Statistic Tool: A Meta-Analysis and Parsing Tool for Polygenic Risk Score Calculation

Motivation: GWAS (genome-wide association study) summary statistic files are essential inputs for polygenic risk score (PRS) calculation. However, identifying suitable files across thousands of catalog entries typically requires downloading large datasets and manually inspecting their column structures, a process that is both time-consuming and storage-intensive. Results: We present GWASPoker, a phenotype-driven, GWAS-Catalog-specific pre-download triage tool that scans candidate GWAS files for PRS column availability through partial downloads and header detection, without requiring full-file transfer. Analysing 60,499 records from the GWAS Catalog, 60,281 (99.6%) contained accessible download links, of which 54,026 (89.6%) were successfully partially downloaded and parsed across 20 file formats, yielding 724 unique header signatures. Across 13 phenotypes, 84 of 85 manually curated GWAS files (98.8%) were automatically retrieved and processed. Header validation against fully downloaded files showed exact agreement in 23 of 28 cases (82.1%). Availability and implementation: GWASPoker is implemented in Python 3 and is freely available at https://github.com/MuhammadMuneeb007/GWASPokerforPRS under the MIT licence. Example outputs and documentation are provided in the repository. The tool was tested on Linux (HPC cluster) with Python 3.8 or later. The LLM-based code-generation step is entirely optional; a rules-based column-mapping template is provided for fully offline use.

q-bio.QM

Identifying genes associated with phenotypes using machine and deep learning

Identifying disease-associated genes enables the development of precision medicine and the understanding of biological processes. Genome-wide association studies (GWAS), gene expression data, biological pathway analysis, and protein network analysis are among the techniques used to identify causal genes. We propose a machine-learning (ML) and deep-learning (DL) pipeline to identify genes associated with a phenotype. The proposed pipeline consists of two interrelated processes. The first is classifying people into case/control based on the genotype data. The second is calculating feature importance to identify genes associated with a particular phenotype. We considered 30 phenotypes from the openSNP data for analysis, 21 ML algorithms, and 80 DL algorithms and variants. The best-performing ML and DL models, evaluated by the area under the curve (AUC), F1 score, and Matthews correlation coefficient (MCC), were used to identify important single-nucleotide polymorphisms (SNPs), and the identified SNPs were compared with the phenotype-associated SNPs from the GWAS Catalog. The mean per-phenotype gene identification ratio (GIR) was 0.84. These results suggest that SNPs selected by ML/DL algorithms that maximize classification performance can help prioritise phenotype-associated SNPs and genes, potentially supporting downstream studies aimed at understanding disease mechanisms and identifying candidate therapeutic targets.

q-bio.GN

An Empirical Analysis of Fine-Tuning Large Language Models on Bioinformatics Literature: PRSGPT and BioStarsGPT

Large language models (LLMs) often lack specialized knowledge for complex bioinformatics applications. We present a reproducible pipeline for fine-tuning LLMs on specialized bioinformatics data, demonstrated through two use cases: PRSGPT, focused on polygenic risk score (PRS) tools, and BioStarsGPT, trained on community forum discussions. The nine-step pipeline integrates diverse data sources, structured preprocessing, prompt-based question-answer (QA) generation (via Google Gemini), natural language inference (NLI) for quality control, semantic deduplication, clustering-based data splitting, and parameter-efficient fine-tuning using LoRA. We fine-tuned three LLMs (LLaMA-3.2-3B, Qwen2.5-7B, Gemma) and benchmarked them on over 14 lexical and semantic metrics. Qwen2.5-7B emerged as the best performer, with BLEU-4 and ROUGE-1 improvements of 82\% and 70\% for PRSGPT and 6\% and 18\% for BioStarsGPT, respectively. The open-source datasets produced include over 28,000 QA pairs for PRSGPT and 154,282 for BioStarsGPT. Human evaluation of PRSGPT yielded 61.9\% accuracy on the PRS tools comparison task, comparable to Google Gemini (61.4\%), but with richer methodological detail and accurate citations. BioStarsGPT demonstrated 59\% conceptual accuracy across 142 curated bioinformatics questions. Our pipeline enables scalable, domain-specific fine-tuning of LLMs. It enables privacy-preserving, locally deployable bioinformatics assistants, explores their practical applications, and addresses the challenges, limitations, and mitigation strategies associated with their development and use.

cs.CL

Comparative Analysis of 47 Context-Based Question Answer Models Across 8 Diverse Datasets

Context-based question answering (CBQA) models provide more accurate and relevant answers by considering the contextual information. They effectively extract specific information given a context, making them functional in various applications involving user support, information retrieval, and educational platforms. In this manuscript, we benchmarked the performance of 47 CBQA models from Hugging Face on eight different datasets. This study aims to identify the best-performing model across diverse datasets without additional fine-tuning. It is valuable for practical applications where the need to retrain models for specific datasets is minimized, streamlining the implementation of these models in various contexts. The best-performing models were trained on the SQuAD v2 or SQuAD v1 datasets. The best-performing model was ahotrod/electra_large_discriminator_squad2_512, which yielded 43\% accuracy across all datasets. We observed that the computation time of all models depends on the context length and the model size. The model's performance usually decreases with an increase in the answer length. Moreover, the model's performance depends on the context complexity. We also used the Genetic algorithm to improve the overall accuracy by integrating responses from other models. ahotrod/electra_large_discriminator_squad2_512 generated the best results for bioasq10b-factoid (65.92\%), biomedical\_cpgQA (96.45\%), QuAC (11.13\%), and Question Answer Dataset (41.6\%). Bert-large-uncased-whole-word-masking-finetuned-squad achieved an accuracy of 82\% on the IELTS dataset.

cs.CL

Auto-ADMET: An Effective and Interpretable AutoML Method for Chemical ADMET Property Prediction

Machine learning (ML) has been playing important roles in drug discovery in the past years by providing (pre-)screening tools for prioritising chemical compounds to pass through wet lab experiments. One of the main ML tasks in drug discovery is to build quantitative structure-activity relationship (QSAR) models, associating the molecular structure of chemical compounds with an activity or property. These properties -- including absorption, distribution, metabolism, excretion and toxicity (ADMET) -- are essential to model compound behaviour, activity and interactions in the organism. Although several methods exist, the majority of them do not provide an appropriate model's personalisation, yielding to bias and lack of generalisation to new data since the chemical space usually shifts from application to application. This fact leads to low predictive performance when completely new data is being tested by the model. The area of Automated Machine Learning (AutoML) emerged aiming to solve this issue, outputting tailored ML algorithms to the data at hand. Although an important task, AutoML has not been practically used to assist cheminformatics and computational chemistry researchers often, with just a few works related to the field. To address these challenges, this work introduces Auto-ADMET, an interpretable evolutionary-based AutoML method for chemical ADMET property prediction. Auto-ADMET employs a Grammar-based Genetic Programming (GGP) method with a Bayesian Network Model to achieve comparable or better predictive performance against three alternative methods -- standard GGP method, pkCSM and XGBOOST model -- on 12 benchmark chemical ADMET property prediction datasets. The use of a Bayesian Network model on Auto-ADMET's evolutionary process assisted in both shaping the search procedure and interpreting the causes of its AutoML performance.

q-bio.BM

Explainable Machine Learning for ICU Readmission Prediction

The intensive care unit (ICU) comprises a complex hospital environment, where decisions made by clinicians have a high level of risk for the patients' lives. A comprehensive care pathway must then be followed to reduce p complications. Uncertain, competing and unplanned aspects within this environment increase the difficulty in uniformly implementing the care pathway. Readmission contributes to this pathway's difficulty, occurring when patients are admitted again to the ICU in a short timeframe, resulting in high mortality rates and high resource utilisation. Several works have tried to predict readmission through patients' medical information. Although they have some level of success while predicting readmission, those works do not properly assess, characterise and understand readmission prediction. This work proposes a standardised and explainable machine learning pipeline to model patient readmission on a multicentric database (i.e., the eICU cohort with 166,355 patients, 200,859 admissions and 6,021 readmissions) while validating it on monocentric (i.e., the MIMIC IV cohort with 382,278 patients, 523,740 admissions and 5,984 readmissions) and multicentric settings. Our machine learning pipeline achieved predictive performance in terms of the area of the receiver operating characteristic curve (AUC) up to 0.7 with a Random Forest classification model, yielding an overall good calibration and consistency on validation sets. From explanations provided by the constructed models, we could also derive a set of insightful conclusions, primarily on variables related to vital signs and blood tests (e.g., albumin, blood urea nitrogen and hemoglobin levels), demographics (e.g., age, and admission height and weight), and ICU-associated variables (e.g., unit type). These insights provide an invaluable source of information during clinicians' decision-making while discharging ICU patients.

cs.LG

Towards Evolutionary-based Automated Machine Learning for Small Molecule Pharmacokinetic Prediction

Machine learning (ML) is revolutionising drug discovery by expediting the prediction of small molecule properties essential for developing new drugs. These properties -- including absorption, distribution, metabolism and excretion (ADME)-- are crucial in the early stages of drug development since they provide an understanding of the course of the drug in the organism, i.e., the drug's pharmacokinetics. However, existing methods lack personalisation and rely on manually crafted ML algorithms or pipelines, which can introduce inefficiencies and biases into the process. To address these challenges, we propose a novel evolutionary-based automated ML method (AutoML) specifically designed for predicting small molecule properties, with a particular focus on pharmacokinetics. Leveraging the advantages of grammar-based genetic programming, our AutoML method streamlines the process by automatically selecting algorithms and designing predictive pipelines tailored to the particular characteristics of input molecular data. Results demonstrate AutoML's effectiveness in selecting diverse ML algorithms, resulting in comparable or even improved predictive performances compared to conventional approaches. By offering personalised ML-driven pipelines, our method promises to enhance small molecule research in drug discovery, providing researchers with a valuable tool for accelerating the development of novel therapeutic drugs.

cs.LG

AI driven B-cell Immunotherapy Design

Antibodies, a prominent class of approved biologics, play a crucial role in detecting foreign antigens. The effectiveness of antigen neutralisation and elimination hinges upon the strength, sensitivity, and specificity of the paratope-epitope interaction, which demands resource-intensive experimental techniques for characterisation. In recent years, artificial intelligence and machine learning methods have made significant strides, revolutionising the prediction of protein structures and their complexes. The past decade has also witnessed the evolution of computational approaches aiming to support immunotherapy design. This review focuses on the progress of machine learning-based tools and their frameworks in the domain of B-cell immunotherapy design, encompassing linear and conformational epitope prediction, paratope prediction, and antibody design. We mapped the most commonly used data sources, evaluation metrics, and method availability and thoroughly assessed their significance and limitations, discussing the main challenges ahead.

q-bio.QM

Known allosteric proteins have central roles in genetic disease

Allostery is a form of protein regulation, where ligands that bind sites located apart from the active site can modify the activity of the protein. The molecular mechanisms of allostery have been extensively studied, because allosteric sites are less conserved than active sites, and drugs targeting them are more specific than drugs binding the active sites. Here we quantify the importance of allostery in genetic disease. We show that 1) known allosteric proteins are central in disease networks, and contribute to genetic disease and comorbidities much more than non-allosteric proteins, in many major disease types like hematopoietic diseases, cardiovascular diseases, cancers, diabetes, or diseases of the central nervous system. 2) variants from cancer genome-wide association studies are enriched near allosteric proteins, indicating their importance to polygenic traits; and 3) the importance of allosteric proteins in disease is due, at least partly, to their central positions in protein-protein interaction networks, and probably not due to their dynamical properties.

q-bio.MN